Fundraising Fox

Anna Turetsky

Investor

General Partner, PxB Fund at OUP (Osage University Partners)

New York, New York, United States

About

Anna Turetsky joined OUP in 2025 as General Partner of the $50M PxB Fund (Penn-BioNTech Innovative Therapeutics Seed Fund), focusing exclusively on life science companies emerging from University of Pennsylvania technologies. She previously launched and led the venture investing arm of the Mark Foundation for Cancer Research and began her career at Lightstone Ventures. She holds a Ph.D. in Biophysics from Harvard University and a B.A. in Biochemistry from the University of Pennsylvania.

Invests in

Biotech

Experience

  1. Osage University Partners (OUP)General Partner, PxB Fundcurrent2025 — present
  2. Verseau TherapeuticsBoard Membercurrent2019 — present
  3. Pommette, LLCStrategy, BD, and Corporate Development2024 — 2026New York, New York, United States
  4. Hyku BiosciencesBoard Observer2023 — 2024Greater Boston
  5. Vicinitas TherapeuticsBoard Observer2022 — 2024South San Francisco, California, United States
  6. Immunitas TherapeuticsBoard Observer2021 — 2024Greater Boston
  7. Interius BioTherapeuticsBoard Observer2020 — 2024Philadelphia, Pennsylvania, United States
  8. Accent Therapeutics, Inc.Board Observer2020 — 2024Greater Boston
  9. The Mark Foundation for Cancer ResearchPrincipal, Venture Investments2019 — 2024New York, New York, United States
  10. C2i GenomicsBoard Observer2020 — 2024New York, New York, United States
  11. Cyteir TherapeuticsBoard Observer2018 — 2019Greater Boston Area
  12. Locana, Inc.Board Observer2017 — 2019Greater San Diego Area
  13. Disarm TherapeuticsBoard Observer2017 — 2019Greater Boston Area
  14. Lightstone VenturesVice President2017 — 2019Boston, Massachusetts, United States
  15. Lightstone VenturesAssociate2015 — 2017Boston, Massachusetts, United States
  16. Gemini TherapeuticsBoard Observer2016 — 2019Greater Boston Area
  17. Tizona Therapeutics, Inc.Board Observer2016 — 2019San Francisco Bay Area
  18. Hydra BiosciencesBoard Observer2015 — 2019Greater Boston Area
  19. Fletcher Spaght, Inc.Analyst, Healthcare Consulting2014 — 2015Greater Boston Area
  20. Center for Systems Biology, Massachusetts General HospitalNSF Graduate Research Fellow2010 — 2014Greater Boston Area

Education

  1. Harvard UniversityPhD, Biophysics2009 — 2014
  2. University of PennsylvaniaBA, Biochemistry (major); Fine Arts2005 — 2009

Investments

Board seats

Verseau Therapeutics

Investor

Accent TherapeuticsC2i GenomicsHyku BiosciencesImmunitas TherapeuticsInterius BioTherapeuticsVicinitas Therapeutics

Per the firm's website.

Colleagues at OUP (Osage University Partners)

Ajay Rayasam
Principal at Osage University Partners
Allen Chen
Principal at Osage University Partners
Beth Grafstrom
Senior Vice President at OUP (Osage University Partners)
Britt Kennett
Senior Executive Assistant at OUP (Osage University Partners)
Brittany de Kouchkovsky
Director, University Relations at Osage University Partners
Chris Nawalinski
Fund Accountant at OUP (Osage University Partners)
Claudia Dunnous
Chief Financial Officer at OUP (Osage University Partners)
Jaimie Testai
Investor at OUP (Osage University Partners)

Frequently asked questions

Where does Anna Turetsky work?
Anna Turetsky is General Partner, PxB Fund at OUP (Osage University Partners).
What does Anna Turetsky invest in?
Anna Turetsky invests in Biotech.

Same school

Also attended Harvard University1,457

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures

+ 1,451 more

Also attended University of Pennsylvania765

Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark Capital

+ 759 more

Shared employers

Also worked at Accent Therapeutics, Inc.3

Christian SchubertHead of AbbVie Ventures at AbbVieCaroline StoutPartner at EcoR1 CapitalChristina VorvisDirector at AbbVie

Also worked at Locana, Inc.1

John LeonardExecutives in Residence at GENERAL INCEPTION

Also worked at Lightstone Ventures10

Adam BrucePartner, Chief Financial and Chief Operating Officer at Flare Capital PartnersCaroline GaynorPartner at Lightstone VenturesHanson S. Gifford, IIIPartner at Lightstone VenturesChristina IsacsonPartner at Lightstone VenturesJuan-Pablo MasPartner at Action Potential Venture Capital Ltd.Robin BellasPartner at Morgenthaler

+ 4 more

Also worked at Gemini Therapeutics2

Lisa HuangSenior Vice President at Curie.BioDiego ReyAngel at Endpoint Ventures